FICCI & NATHEALTH Sign MoU to jointly strengthen Healthcare Systems & Public-Private-Partnerships

New Delhi: The Federation of Indian Chambers of Commerce and Industry (FICCI), the leading industry body, has signed a Memorandum of Understanding (MoU) with the healthcare industry body -Healthcare Federation of India (NATHEALTH) to jointly strengthen healthcare systems through Policy Advocacy & Public-Private-Partnerships. The MoU aims to provide a wider representation of the healthcare industry to key stakeholders in areas of policymaking and creating a suitable environment to benefit all stakeholders.

Under the agreement, two apex industry bodies intent to co-operate and focus their efforts on creating and implementing policies that help build trust, share knowledge and resource and create commercial opportunities for the mutual benefit of its members.

Through this collaboration, FICCI and NATHEALTH have identified five major areas of collaboration viz. Policy Advocacy, Public-private partnership, Recommending financial models, Patient Charter and Capacity Building.They have alsoagreed to develop a common minimum agenda for the year, aligned to national healthcare goals and work towards getting the government’s support in taking this agenda forward.

(Hony.) Brig Dr Arvind Lal, Chair, FICCIHealth Services, while signing the MoU said, “FICCI has set up several Task Forces to recommend measures for strengthening number of specialist doctors, pricing and accountability in healthcare and bridging the trust deficit. Through this collaboration both FICCI and NATHEALTH would be able to present a unified voice for the healthcare industry in critical areas such as capacity building, quality and Patient Charter”.

“We have common interest and objectives. We will establish channels of communication and co-operation that will promote and advance the objectives of the members through common dialogue and representation. NATHEALTH, in association with FICCI, will formulate joint representations on behalf of the members on matters relating to successful implementation of government’s program under National Health Mission including AB-PMJAY,” said Dr H Sudarshan Ballal, President,  NATHEALTH.  

Capacity building in Tier II & III cities is a priority for the government and the industry is committed to extending all its support. FICCI and NATHEALTH will work together in recommending reference cost structure for building and operating hospitals in non-metro locations and suggesting models for revenue and costing that meets the ‘inclusive healthcare’ objective of the government.

Dr Lal added, “while we would work towards capacity creation in smaller cities and recommend locations that are best suited for the government to initiate public-private partnerships, we will also explore sustainable PPP/philanthropic/CSR modelsfor efficient running of the 150,000 HWCs under Ayushman Bharat for imparting quality primary healthcare, control of NCDs and availability of high quality diagnostics”

Related Posts

  • Health
  • February 10, 2024
  • 26 views
Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

Millets reigned Supreme in International Symposium on Gut Health

New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Significant Decline In Pharma Deals In Q1

Significant Decline In Pharma Deals In Q1

Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

Glenmark recalls 6,528 bottles of BP drug in US

Glenmark recalls 6,528 bottles of BP drug in US

Pharma Exports To US Surges 15% In 11 Months Of FY24

Pharma Exports To US Surges 15% In 11 Months Of FY24

CAHO Naa Patients Se Pyaar Hai

CAHO Naa Patients Se Pyaar Hai